4D Molecular Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $560.4M
Liabilities Breakdown FY2024
Total Liabilities: $49.8M
Asset Breakdown
Total Assets: $560.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $149.3M | 26.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $19.5M | 3.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $391.5M | 69.9% |
Liabilities Breakdown
Total Liabilities: $49.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.4M | 8.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $45.4M | 91.2% |